Enalapril (Ep01)
Chemical structure of enalapril maleate, showing the molecular arrangement of enalapril combined with maleic acid as its salt form.*
Enalapril Maleate
Product Images NDC 51138-036
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Enalapril Maleate (NDC 51138-036). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Med Health Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Label (Lb01)
Four separate label panels for Enalapril Maleate Tablets, USP by Med Health Pharma, LLC, showing strengths of 2.5 mg, 5 mg, 10 mg, and 20 mg. Each label states 30 tablets per package, includes storage instructions to keep below 30°C and avoid temperatures above 50°C, and notes federal law restrictions. Manufactured by Wockhardt Limited, Mumbai, India, and repackaged by Med Health Pharma in North Las Vegas, NV.*
Tabel-1 (Tb01)
A data table comparing the incidence of various side effects for Enalapril Maleate versus placebo groups across multiple body systems, including fatigue, orthostatic effects, asthenia, digestive issues, nervous/psychiatric symptoms, respiratory effects, and skin reactions.*
Tabel-2 (Tb02)
A data table presenting the incidence of discontinuation due to various adverse effects comparing Enalapril Maleate (n=673) and Placebo (n=339). The table categorizes events under body systems including cardiovascular, digestive, nervous/psychiatric, respiratory, skin, and urogenital, listing specific conditions with corresponding incidence rates for each group.*
Tabel-3 (Tb03)
A table detailing initial dose recommendations of Enalapril Maleate based on renal status. It lists creatinine clearance ranges and corresponding initial dosages in mg/day for normal renal function, mild impairment, moderate to severe impairment, and dialysis patients, with accompanying footnotes regarding warnings and dose adjustments during dialysis.*
Tabel-4 (Tb04)
A data table listing Enalapril Maleate Tablets, USP, with NDC numbers, strengths (2.5 mg, 5 mg, 10 mg, 20 mg), detailed tablet descriptions including color and physical characteristics, and packaging as 30's bottles. The labeler is Med Health Pharma, LLC.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
